A detailed history of Tcg Advisory Services, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Tcg Advisory Services, LLC holds 10,112 shares of ADMA stock, worth $200,217. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,112
Previous 15,350 34.12%
Holding current value
$200,217
Previous $306,000 43.46%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

SELL
$15.62 - $22.62 $81,817 - $118,483
-5,238 Reduced 34.12%
10,112 $173,000
Q3 2024

Nov 14, 2024

SELL
$11.21 - $20.03 $22,375 - $39,979
-1,996 Reduced 11.51%
15,350 $306,000
Q2 2024

Aug 09, 2024

SELL
$5.98 - $11.18 $3,067 - $5,735
-513 Reduced 2.87%
17,346 $193,000
Q1 2024

May 10, 2024

BUY
$4.4 - $6.74 $78,579 - $120,369
17,859 New
17,859 $117,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.89B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Tcg Advisory Services, LLC Portfolio

Follow Tcg Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcg Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tcg Advisory Services, LLC with notifications on news.